BA
AMGN icon

Boston Advisors’s Amgen AMGN Stock Holding History

Boston Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$6.39M Buy
33,036
+593
+2% +$114K 0.33% 80
2019
Q2 		$5.98M Sell
32,443
-3,790
-10% -$679K 0.32% 83
2019
Q1 		$6.88M Sell
36,233
-19,261
-35% -$3.68M 0.35% 72
2018
Q4 		$10.8M Buy
55,494
+1,239
+2% +$242K 0.62% 32
2018
Q3 		$11.2M Sell
54,255
-9,829
-15% -$1.94M 0.49% 38
2018
Q2 		$11.8M Sell
64,084
-10,985
-15% -$1.94M 0.3% 83
2018
Q1 		$12.8M Sell
75,069
-155,846
-67% -$28.6M 0.33% 84
2017
Q4 		$40.2M Buy
230,915
+778
+0.3% +$138K 0.87% 16
2017
Q3 		$42.9M Buy
230,137
+1,292
+0.6% +$229K 0.97% 13
2017
Q2 		$39.4M Sell
228,845
-78,471
-26% -$12.8M 0.91% 13
2017
Q1 		$50.4M Sell
307,316
-12,012
-4% -$2M 1.19% 9
2016
Q4 		$46.7M Sell
319,328
-53,075
-14% -$7.99M 1.12% 8
2016
Q3 		$62.1M Sell
372,403
-80,850
-18% -$13.7M 1.53% 6
2016
Q2 		$69M Sell
453,253
-3,225
-0.7% -$501K 1.72% 3
2016
Q1 		$68.4M Sell
456,478
-16,866
-4% -$2.51M 1.68% 5
2015
Q4 		$76.8M Buy
473,344
+228,154
+93% +$35.9M 1.8% 4
2015
Q3 		$33.9M Sell
245,190
-6,797
-3% -$1.07M 1.27% 6
2015
Q2 		$38.7M Sell
251,987
-8,420
-3% -$1.35M 1.61% 4
2015
Q1 		$41.6M Buy
260,407
+10,710
+4% +$1.69M 1.65% 2
2014
Q4 		$39.8M Sell
249,697
-8,888
-3% -$1.38M 1.68% 4
2014
Q3 		$36.3M Sell
258,585
-49,287
-16% -$6.43M 1.54% 5
2014
Q2 		$36.4M Buy
307,872
+4,347
+1% +$503K 1.56% 5
2014
Q1 		$37.4M Buy
303,525
+115,495
+61% +$14M 1.67% 4
2013
Q4 		$21.5M Buy
188,030
+12,383
+7% +$1.41M 1.02% 18
2013
Q3 		$19.7M Sell
175,647
-17,607
-9% -$1.91M 1.04% 19
2013
Q2 		$19.1M Buy
+193,254
New +$20.1M 0.92% 32

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boston Advisors's AMGN Position: Q3 2019 in Review

Boston Advisors increased its Amgen (AMGN) stake by 1.8% in Q3 2019, buying an estimated $114K and bringing the position to 33,036 shares worth $6.39M. The position accounts for 0.33% of the portfolio, ranked #80.

Boston Advisors first reported a position in AMGN in Q2 2013 and has held it in 26 quarters since. The position peaked at $76.8M in Q4 2015. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Boston Advisors held 33,036 shares of Amgen worth $6.39M as of Q3 2019.
  • Boston Advisors bought 593 Amgen shares in Q3 2019, an estimated $114K.
  • Amgen made up 0.33% of Boston Advisors's portfolio in Q3 2019, its #80 holding.
  • Boston Advisors first reported a position in Amgen in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Amgen position peaked at $76.8M in Q4 2015.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.